Sorin is now LivaNova. Learn more here

PARADYM RF CRT-D

20_det_paradym_rf_crt_C_v1.jpg

The PARADYM RF CRT-D has self-adjusting technology that thinks like you.

  • PARAD+ Analyzes arrhythmias as an electrophysiologist would
  • BTO (Brady-Tachy Overlap) ensures pacing at exercise rate while allowing for unmatched accuracy for slow VT discrimination1,2
  • SMARTVIEW Remote Monitoring makes follow-up easy, allowing for faster decision making from reports that are focused and that contain fewer and more relevant alerts

 

References

  1.  Anselme F, Mletzko R, Bowes R, et al. Prevention of Inappropriate Shocks in ICD Recipients: A review of 10,000 tachycardia episodes. PACE 2007; 30:S128-33.
  2. Sadoul N, Mletzko R, Anselme F, et al. Incidence and clinical relevance of slow ventricular tachycardia in implantable cardioverter-defibrillator recipients: an international multicenter prospective study. Circulation 2005;112:946-53

Features

Fewer inappropriate shocks with PARAD+

PARAD+ analyzes arrhythmias as an electrophysiologist would.

Protects patients with best-in-class 99% SVT specificity1

  • Only 2.6% of patients received inappropriate shocks at 1 year with PARAD+ out of the box settings2

 

Efficient Resynchronization for active patients with BTO (Brady-Tachy Overlap)

BTO ensures pacing at exercise rate while allowing unmatched accuracy for slow VT discrimination3,4

  • Allows patients to be paced in the slow VT zone to favor exercise. Exercise training is part of the treatment of HF patients, reducing mortality and improving QoL5,6

 


Faster decisions from focused reports with Smartview Remote Monitoring

SMARTVIEW Remote Monitoring generates reports that take you instantly to the heart of therapy.

  • Important clinical insights are presented first
  • All transmissions come with IEGM and full follow-up

Alerts organized according to the level of severity

  • High PARAD+ specificity minimizes irrelevant alerts

Supported by a dedicated help desk

 

References

  1. Hintringer F, Deibl M, Berger T, Pachinger O, Roithinger FX. Comparison of the specificity of implantable dual chamber defibrillator detection algorithms. PACE 2004; 27:976-82.
  2. Option study – Late breaking trials – Europace 2013 – Sorin data on file
  3. Anselme F, Mletzko R, Bowes R, et al. Prevention of Inappropriate Shocks in ICD Recipients: A review of 10,000 tachycardia episodes. PACE 2007; 30:S128-33.
  4. Sadoul N, Mletzko R, Anselme F, et al. Incidence and clinical relevance of slow ventricular tachycardia in implantable cardioverter-defibrillator recipients: an international multicenter prospective study. Circulation 2005;112:946-53.
  5.  Hunt SA,et al. ACC/AHA 2005 Guideline Update  for the Diagnosis and Management of Chronic Heart Failure in the Adult. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2005; 112:e154-e235.
  6. Swedberg, et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J 2005; 26; 1115-1140

 

This product may not be for sale in your country or your area. For further information on product availability, please contact your local representative

Caution: Federal law (USA) restricts this device to sale by or on the order of a physician. For indications, contraindications, precautions and warnings for each device, please refer to the Instructions For Use

Version unknown | Revision 110938 | Status unstable | SessionId 8ECB01ED4F4C0D0C3225A43E554E3F0C.jvm0